HBV reactivation in HCC patients following TACE: risk factors, antiviral therapy impact, and survival analysis.
Saved in:
| Title: | HBV reactivation in HCC patients following TACE: risk factors, antiviral therapy impact, and survival analysis. |
|---|---|
| Authors: | Zhang H; Department of Interventional Radiology, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong, China., Du JH; Department of Interventional Radiology, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong, China., Lu ZY; Department of Interventional Radiology, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong, China., Wu DD; Department of Interventional Radiology, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong, China., Ma L; Department of Interventional Radiology, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong, China., Yang JY; Department of Interventional Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China., Huang YH; Department of Interventional Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China., Zhang YQ; Department of Interventional Radiology, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong, China. |
| Source: | Frontiers in oncology [Front Oncol] 2026 Apr 28; Vol. 16, pp. 1818955. Date of Electronic Publication: 2026 Apr 28 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2026.1818955 |
